Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) – Analysts’ Revisions Point To Positive Sentiment

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) traded at $0.29 at close of the session on current trade day and made a downward move of -7.81% on its previous day’s price.

Looking at the stock we see that its previous close was $0.31 and the beta (5Y monthly) reads 2.077 with the day’s price range being $0.2826 – $0.3048. In terms of its 52-week price range, TNXP has a high of $12.48 and a low of $0.12. The company’s stock has gained about 67.01% over that past 30 days.

Tonix Pharmaceuticals Holding Corp has a market cap of $53.84 million and is expected to release its quarterly earnings report in February.

On the other hand, looking at the outlook for the TNXP stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of Hold.

Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Tonix Pharmaceuticals Holding Corp (TNXP) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is -16.21% off its SMA20 and 22.37% from its 50-day simple moving average. The RSI (14) is pointing at 48.15 while the volatility over the past week is 14.79% and jumps to 40.62% over the past one month. The beta value is 2.05, while the average true range (ATR) is currently pointing at 0.10.

Coming back to Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), we note that the average 3-month trading volume was 101.19 million, while that of the preceding 10-day period stands at 118.92 million. Current shares outstanding are 186.89 million.

The insiders hold 0.00% of the company’s shares while institutions hold 2.21%. The data shows that short shares as of 2024-10-31, stood at 7.67 million at a short ratio of 0.35. This represents a 548.00 short interest in shares outstanding on 2024-10-31. Shares short fall in October from the previous month at 8.29 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -12.64% down in year-to-date price movement.

Most Popular